Lansoprazole
Product Images NDC 42254-227

4 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 42254-227). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Structural Formula (A9465919 2a5f 40f9 A8e4 Ce75f7a651d4 01)

Lansoprazole Structural Formula (A9465919 2a5f 40f9 A8e4 Ce75f7a651d4 01)
Chemical structure of the active ingredient Lansoprazole, showing its molecular framework with characteristic pyridine and benzimidazole rings and associated functional groups.*
FDA Label Image

Figure 1 (A9465919 2a5f 40f9 A8e4 Ce75f7a651d4 02)

Figure 1 (A9465919 2a5f 40f9 A8e4 Ce75f7a651d4 02)
A line graph showing mean severity of day heartburn over approximately 60 days from the start of treatment. It compares three groups: placebo, lansoprazole 15 mg QD, and lansoprazole 30 mg QD, with severity values on the vertical axis and days on the horizontal axis. The lansoprazole groups show a decrease in heartburn severity over time compared to placebo.*
FDA Label Image

Figure 2 (A9465919 2a5f 40f9 A8e4 Ce75f7a651d4 03)

Figure 2 (A9465919 2a5f 40f9 A8e4 Ce75f7a651d4 03)
A line graph depicting the mean severity of night heartburn over days from the start of treatment. It compares three groups: placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily, showing a decrease in severity over time for both Lansoprazole doses compared to placebo.*
FDA Label Image

Lansoprazole 30mg (A9465919 2a5f 40f9 A8e4 Ce75f7a651d4 04)

Lansoprazole 30mg (A9465919 2a5f 40f9 A8e4 Ce75f7a651d4 04)
Label for Lansoprazole 30mg delayed-release capsules by Rebel Distributors Corp under the brand Physician Partner. The label includes dosage strength, capsule description, lot number, expiration date, NDC 42254-227-60, and manufacturer Teva Pharmaceutical Industries Ltd., Jerusalem, Israel. Storage instructions and safety warnings are provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.